Cargando…
Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study
AIMS/HYPOTHESIS: The aim of this cohort study was to investigate the risk of malignant neoplasms and mortality in patients with diabetes treated either with human insulin or with one of three insulin analogues. METHODS: Data were provided by the largest German statutory health insurance fund (time-f...
Autores principales: | Hemkens, L. G., Grouven, U., Bender, R., Günster, C., Gutschmidt, S., Selke, G. W., Sawicki, P. T. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2723679/ https://www.ncbi.nlm.nih.gov/pubmed/19565214 http://dx.doi.org/10.1007/s00125-009-1418-4 |
Ejemplares similares
-
Doses of Insulin and Its Analogues and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients
por: Mannucci, Edoardo, et al.
Publicado: (2010) -
Therapeutics of Diabetes Mellitus: Focus on Insulin Analogues and Insulin Pumps
por: Valla, Vasiliki
Publicado: (2010) -
Cancer risk among insulin users: comparing analogues with human insulin in the CARING five-country cohort study
por: But, Anna, et al.
Publicado: (2017) -
Review of Insulin and its Analogues in Diabetes Mellitus
por: Mane, Krishnappa, et al.
Publicado: (2012) -
Insulin Icodec Weekly: A Basal Insulin Analogue for Type 2 Diabetes
por: Bajaj, Harpreet S, et al.
Publicado: (2023)